RNLS anticorps (Middle Region)

N° du produit ABIN2788137

Détail du produit anti-RNLS anticorps

Antigène: RNLS (Renalase, FAD-Dependent Amine Oxidase (RNLS))

Épitope: Middle Region

Reactivité: Humain, Souris, Rat, Chien, Cheval, Porc, Lapin, Cobaye

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp RNLS est non-conjugé

Application: Western Blotting (WB)

Séquence: GMKIGVPWSC RYLSSHPCIC FISIDNKKRN IESSECGPSV VIQTTVPFGV

Homologie: Dog: 79%, Guinea Pig: 93%, Horse: 100%, Human: 100%, Mouse: 100%, Pig: 100%, Rabbit: 100%, Rat: 100%

Attributs du produit: This is a rabbit polyclonal antibody against Rnls. It was validated on Western Blot.

Purification: Affinity Purified

Information d'application

Indications d'application: Optimal working dilutions should be determined experimentally by the investigator.

Commentaires:

Antigen size: 300 AA

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freeze-thaw cycles.

Stock: -20 °C

Stockage commentaire: For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.

Détails sur RNLS

Antigène: RNLS (Renalase, FAD-Dependent Amine Oxidase (RNLS))

Autre désignation: Rnls (RNLS Produits)

Synonymes: anticorps zgc:92286, anticorps C10orf59, anticorps RENALASE, anticorps 6530404N21Rik, anticorps AI452315, anticorps AW060440, anticorps RGD1309804, anticorps renalase, FAD dependent amine oxidase, anticorps renalase, FAD-dependent amine oxidase, anticorps RNLS, anticorps rnls, anticorps Rnls

Sujet: Rnls is a probable FAD-dependent amine oxidase secreted by the kidney, which circulates in blood and modulates cardiac function and systemic blood pressure. It degrades catecholamines such as dopamine, norepinephrine and epinephrine in vitro. It lowers blood pressure in vivo by decreasing cardiac contractility and heart rate and preventing a compensatory increase in peripheral vascular tone, suggesting a causal link to the increased plasma catecholamine and heightened cardiovascular risk. High concentrations of catecholamines activate plasma renalase and promotes its secretion and synthesis.
Alias Symbols: 6530404N21Rik, AI452315, AW060440, C10orf59
Protein Size: 300

Poids moléculaire: 33 kDa

ID gène: 67795

NCBI Accession: NM_001167818, NP_001161290

UniProt: A7RDN6